Human African Trypanosomiasis: Clinical Trials

1 trial for Human African Trypanosomiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Human African Trypanosomiasis: new trials by email Literature Review of Human African Trypanosomiasis trials Research Report on Human African Trypanosomiasis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
Nifurtimox-Eflronithine Combination Treatment (NECT) - Human African Trypanosomiasis
Phase 4CompletedDrugs for Neglected Diseases6302009-04-012013-05-31

Narrower conditions

Trypanosomiasis, African (1)

Broader conditions

Euglenozoa Infections (1)  ·  Infections (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Trypanosomiasis (1)  ·  Vector Borne Diseases (1)

Interventions

Eflornithine (1)  ·  Nifurtimox (1)

Sponsors

Drugs for Neglected Diseases (1)

Countries

Republic of the Congo (1)

Top investigators

Johannes Blum, MD (1)  ·  Victor Kande, MD (1)

Results publications

PMID 23209861, PMID 31986140, PMID 34748572